USE OF (4-HYDROXY-2-METHYL-1,1-DIOXIDO-2H-BENZO[E][1,2]THIAZINE-3-YL)(NAPHTHALENE-2-YL) METHANONE IN THE PREVENTION AND/OR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
The present invention relates to (4-hydroxy-2-methyl-1,1-dioxido-2H-benzo [e][1,2]thiazine-3-yl)(naphthalen-2-yl)methanone or one of the salts thereof, pharmaceutically acceptable for use in the prevention and/or treatment of hepatic steatosis, including non-alcoholic steatohepatitis or one of the complications of same.La présente invention concerne la (4-hydroxy-2-méthyl-1,1-dioxido-2H-benzo [e] [1,2] thiazin-3-yl) (naphthalen-2-yl ) méthanone ou l'un de ses sels pharmaceutiquement acceptables pour son utilisation dans la prévention et/ou le traitement de la stéatose hépatique, incluant la stéatohépatite non-alcoolique ou l'une de ses complications.